KL2 Scholar Content

Consortium News

Discrimination may affect the health and well-being of women of color according to research presented by Yendelela Cuffee, PhD, MPH, assistant professor of public health sciences at Penn State College more

Consortium News

Medical decision making is a complicated topic, involving not just estimates of disease risk or prognosis, but a host of other issues like physician judgment, patient preferences, cost effectiveness of different therapies, and the patient’s desired degree of participation in the decision-making more

Consortium News

Sexual minorities — people who are attracted to members of the same sex or who identify as gay, lesbian or bisexual — are at a higher risk for several different health problems at different points in their lives, according to Penn State researchers. 

The researchers found that sexual more

Consortium News

Clinical and Translational Science Collaborative (CTSC) KL2 Scholar alumna, Allison Webel  RN, PhD, FAAN, received a four-year, $3-million grant from the National Heart, Lung, and Blood Institute to fund her study “A Nurse-Led Intervention to Extend the HIV Treatment Cascade for Cardiovascular more

Consortium News

Social worker and public health researcher Tina Studts and otolaryngologist Matt Bush have been collaborating in community-engaged research for six years, since they first met as KL2 Scholars. Their work has culminated in an R01 grant to implement and study a family support program for children more

Consortium News

Penn State Clinical and Translational Science Institute has welcomed a new scholar into its program that invests in early-career faculty. Dr. Steven Hicks more

Consortium News

Mohamed Abazeed, MD, PhD became a CTSC KL2 Scholar in 2015. His research program focuses on identifying the genetic abnormalities that give rise to therapeutic resistance in cancer and using this information to develop personalized therapeutic strategies in a new strategy of biologically-guided more

Consortium News

Mohamed Abazeed, MD, PhD became a CTSC KL2 Scholar in 2015 under the mentorship of Michael Kattan, PhD and Jaroslaw Maciejewski, MD, PhD at the Cleveland Clinic. Dr. Abazeed's research program focuses on identifying the genetic abnormalities that give rise to therapeutic resistance in cancer and more

Twitter logoFollow CLIC
Twitter logoFollow NCATS